HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer (2020) Würfel FM, Wirtz RM, Winterhalter C, Taffurelli M, Santini D, Mandrioli A, Veltrup E, et al. Journal article Use of a molecular Registry (PRAEGNANT) for Patient-Selection and Biomarker-Analysis for the SHERBOC Study (2020) Hübner H, Kurbacher C, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Conference contribution Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry - comparison of three different prognostic scores (2020) Riecke K, Mueller , Neunhoeffer T, Weide R, Schmidt M, Park-Simon TW, Mundhenke C, et al. Conference contribution The Work- and Further Training Situation of young Doctors in Further Training in Gynecology - A Standpoint (2020) Lermann J, Knabl J, Neimann J, Schulte K, Proske K, Schott S, Raspe M Conference contribution Gynecologists ' attitude towards their use of complementary and integrative medicine approaches: results of a nationwide AGO IMed survey (2020) Grimm D, Paepke D, Voiss P, Cramer H, Kuemmel S, Beckmann M, Kalder M, et al. Conference contribution Influence of sonographic fetal weight estimation in (suspected) fetal macrosomia on perinatal outcome (2020) Pretscher J, Kehl S, Stelzl P, Stumpfe F, Mayr A, Schmid M, Staerk C, et al. Conference contribution Influence of the Family Anamnesis of Breast or Ovarian Cancer on the pathological Complete Remission and the Prognosis in Patients with Breast Cancer after neoadjuvant Chemotherapy (2020) Gaß P, Haberle L, Hein A, Jud S, Lux MP, Hack C, Emons J, et al. Conference contribution Accuracy of vulvoscopic findings in detecting early vulvar neoplasia (2020) Stuebs FA, Mehlhorn G, Gaß P, Schulmeyer C, Adler W, Strehl J, Hartmann A, et al. Conference contribution Fertility Preservation: Optimization of Follicle Extraction before Cultivation in the Artificial Ovary (2020) Keckstein P, Fattahi A, Liverani L, Dittrich R, Hoffmann I, Boccaccini AR, Beckmann M, Bleisinger N Conference contribution Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup (2020) Emons J, Fasching P, Wunderle M, Heindl F, Rieger J, Horn F, Pelzer G, et al. Conference contribution